<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04463212</url>
  </required_header>
  <id_info>
    <org_study_id>RC20_0280</org_study_id>
    <nct_id>NCT04463212</nct_id>
  </id_info>
  <brief_title>Endothelial Dysfunction in Reversible Cerebral Vasoconstriction Syndrome</brief_title>
  <acronym>DESS</acronym>
  <official_title>Systemic Endothelial Dysfunction in Reversible Cerebral Vasoconstriction Syndrome : a Case Control Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nantes University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Nantes University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Reversible Cerebral Vasoconstriction Syndrome (RCVS) is a syndrome described at the end of&#xD;
      the 20th century. Generally, it has a benign course. It is revealed by acute headaches, in&#xD;
      different circumstances such as sexual activity, physical exertion or emotional disturbances.&#xD;
      But, in few cases, it might be complicated by seizure, stroke and subarachnoid haemorrhage.&#xD;
      The diagnosis is confirmed on radiological examination, which shows diffuse cerebral&#xD;
      vasoconstriction of brain vessel. It calls reversible because at three month,&#xD;
      vasoconstriction disappears. Most cases occur during post partum or after&#xD;
      serotoninergic/adrenergic drug use. The pathophysiology is unknown but a transient&#xD;
      disturbance in the control of cerebrovascular tone by sympathic hyperactivity and/or&#xD;
      endothelial dysfunction are suspected. The assessment of endothelial dysfunction in brain is&#xD;
      possible with transcranial doppler. Chen et al. showed an impairment of vasodilatation post&#xD;
      apnea induced called BHI on RCVS subjects compared with healthy control. BHI is a reflect of&#xD;
      endothelial function in brain. Currently, investigators do not know if endothelial&#xD;
      dysfunction occurred only in brain or if it may occur in systemic vessel. Some case reports&#xD;
      talk about systemic complication such as kidney infarct or hepatic arterial vasospasm so a&#xD;
      systemic vascular dysfunction may be suspected. In this study, researchers will study&#xD;
      systemic endothelial function by measure of the pulse wave velocity during RCVS and after its&#xD;
      recovering at 3 months, and compare it at healthy controls.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigators lead a case control study to find a systemic endothelial dysfunction by the&#xD;
      using of Complior device. Complior is a mechanographer who calculates pulse wave velocity&#xD;
      (PWV). Pulse wave velocity is a reflect of arterial stiffness and it's correlate with&#xD;
      endothelial dysfunction. For BHI, a Philips echograph is used before and after 30 second of&#xD;
      breath holding.&#xD;
&#xD;
      Study protocol is :&#xD;
&#xD;
      For Patient :&#xD;
&#xD;
        -  Day 0 : in hospital : anamnesis, medical history, physic examination, EKG, blood sample&#xD;
           analysis, BHI, PWV analysis&#xD;
&#xD;
        -  Month 1 : in medical visit : medical evolution, physic examination, EKG, blood sample&#xD;
           analysis, BHI, PWV analysis&#xD;
&#xD;
        -  Month 3 : in medical visit : medical evolution, physic examination, EKG, blood sample&#xD;
           analysis, BHI, PWV analysis, cerebral angioCT Scan&#xD;
&#xD;
      For control :&#xD;
&#xD;
      - Day 0 : in hospital : medical history, physic examination, EKG, BHI, PWV analysis&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 29, 2021</start_date>
  <completion_date type="Anticipated">January 1, 2023</completion_date>
  <primary_completion_date type="Anticipated">January 1, 2023</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Compare systemic endothelial function between patient and healthy subject</measure>
    <time_frame>24 hours</time_frame>
    <description>By using Complior, researchers assess systemic endothelial function at inclusion on patient and healthy volunteer person by pulse wave velocity (cm.s-1)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>BHI (Breath Holding Index)</measure>
    <time_frame>at day 0, month 1, month 3</time_frame>
    <description>BHI measure on middle cerebral arteries by transcranial ultrasound</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pulse wave velocity (PWV)</measure>
    <time_frame>at day 0, month 1, month 3</time_frame>
    <description>Pulse wave velocity mesaure from carotid to femoral artery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Relationship between cerebral and systemic endothelial function</measure>
    <time_frame>at day 0, month 1, month 3</time_frame>
    <description>Comparison of BHI and VOP evolution</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Renal failure</measure>
    <time_frame>Day 0</time_frame>
    <description>Diminution of creatinin clearance&lt;100 ml/min/1.73m2</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Occurence of stroke or cerebral oedema</measure>
    <time_frame>at day 0, month 1, month 3</time_frame>
    <description>Occurrence of ischemic stroke, cerebral haemorrhage, cerebral oedema</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Comparison of PWV between patients with or without arterial hypertension</measure>
    <time_frame>at day 0, month 1, month 3</time_frame>
    <description>Comparison between middle PWV (cm/s) of patients with arterial hypertension and patients without arterial hypertension</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Comparison of BHI between patients with or without arterial hypertension</measure>
    <time_frame>at day 0, month 1, month 3</time_frame>
    <description>Comparison between middle BHI of patients with arterial hypertension and patients without arterial hypertension</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Comparison between PWV (cm/s)</measure>
    <time_frame>at 3 months</time_frame>
    <description>Comparison between PWV (cm/s) between patients and control group</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Comparison between BHI (cm/s)</measure>
    <time_frame>at 3 months</time_frame>
    <description>Comparison between BHI (cm/s) between patients and control group</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">62</enrollment>
  <condition>Reversible Cerebral Vasoconstriction Syndrome</condition>
  <arm_group>
    <arm_group_label>Patient</arm_group_label>
    <description>Diagnosis of probable SVCR evoked, faced with a single or repeated episode of unusual thunderclap or rapidly progressive headache, and demonstration of diffuse vasospasms via sectional imaging (angiography, angio-MRI or cerebral arteriography) or an increase in transcranial doppler speeds</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Subject control</arm_group_label>
    <description>Subject without SVCR (current and history)</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patients and Healthy subjects&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria for patients :&#xD;
&#xD;
          -  Aged from 18 to 80 years old&#xD;
&#xD;
          -  RVCS diagnosis evoked on clinic and radiologic finding&#xD;
&#xD;
          -  Last headache was 15 days ago&#xD;
&#xD;
          -  Oral consent&#xD;
&#xD;
          -  Register in French social security&#xD;
&#xD;
        Inclusion criteria for control :&#xD;
&#xD;
          -  Aged from 18 to 80 years old&#xD;
&#xD;
          -  Hypothesis of RCVS in clinical presentation and on cerebral imaging&#xD;
&#xD;
          -  Last headache less than 3 days old&#xD;
&#xD;
          -  Oral consent&#xD;
&#xD;
          -  Register in French social security&#xD;
&#xD;
          -  Person under guardianship, curatorship or safeguarding of justice&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        Non inclusion criteria for patient :&#xD;
&#xD;
          -  Pregnant women&#xD;
&#xD;
          -  Tobacco, coffee, alcohol, drugs or vasoactive recreational substances use within 2&#xD;
             hours prior to the examination.&#xD;
&#xD;
          -  Person under guardianship, curatorship or safeguarding of justice&#xD;
&#xD;
          -  Non sinusal rhythm on EKG&#xD;
&#xD;
          -  Impossible of Breath holding for 30 secondes&#xD;
&#xD;
        Exclusion criteria for patient :&#xD;
&#xD;
        - No reversibility at 3 months&#xD;
&#xD;
        Non inclusion criteria for control :&#xD;
&#xD;
          -  Pregnant women&#xD;
&#xD;
          -  Tobacco, coffee, alcohol, drugs or vasoactive recreational substances use within 2&#xD;
             hours prior to the examination.&#xD;
&#xD;
          -  Non sinusal rhythm on EKG&#xD;
&#xD;
          -  Impossible of Breath holding for 30 secondes&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Solène DE GAALON, PhD</last_name>
    <phone>02 40 16 52 12</phone>
    <email>Solene.DEGAALON@chu-nantes.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Annick COULON</last_name>
    <phone>02 53 48 28 35</phone>
    <email>bp-prom-regl@chu-nantes.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Nantes University Hospital</name>
      <address>
        <city>Nantes</city>
        <state>Loire-Atlantique</state>
        <zip>44093</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Solene DE GAALON, PH</last_name>
      <phone>33240165212</phone>
      <email>solene.degaalon@chu-nantes.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>July 3, 2020</study_first_submitted>
  <study_first_submitted_qc>July 3, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">July 9, 2020</study_first_posted>
  <last_update_submitted>February 4, 2021</last_update_submitted>
  <last_update_submitted_qc>February 4, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 9, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Endothelial dysfunction</keyword>
  <keyword>Reversible cerebral vasoconstriction syndrome</keyword>
  <keyword>Arterial stiffness</keyword>
  <keyword>Breath holding index</keyword>
  <keyword>Pulse wave velocity</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

